India: Patent

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
From Absolute Prohibition To Conditional Innovation – Section 4 Of The Indian Patents Act And The Transformative Impact Of The Shanti Act 2025
National security has been a cornerstone of India’s patent legislation since its inception. Section 4 of the Indian Patents Act, 1970, exemplifies this priority by imposing an absolute bar on patenting inventions related to atomic energy. This prohibition has historically reflected the government’s exclusive control over nuclear technology and the strategic sensitivity associated with atomic energy. However, India’s evolving clean-energy objectives are driving a significant policy transformation.
India IP
SR
S.S. Rana & Co. Advocates
Article
Mobile Phone Manufacturing Scheme (MPMS): India’s Next Leap In Electronics Manufacturing
On 31 July 1995, India heard its first mobile ring, when the then Union Minister of Communications spoke from Delhi to the then Chief Minister of West Bengal in Kolkata. For most of the two decades that followed, India consumed mobile phones without making them. In 2014, the country had only two mobile phone manufacturing units and was approximately 78% import dependent, with roughly 75% of domestic demand in 2014-15 being met through imports. Today, India has over 300 mobile manufacturing units and imports account for about 0.02% of domestic demand.
India Media & IT
SR
S.S. Rana & Co. Advocates
Article
USPTO Streamlined Claim Set Pilot Program: A Strategic Pathway To Accelerated Patent Examination
Patent pendency remains one of the most significant challenges in U.S. patent prosecution. Average first-action wait times range from approximately 20 to 29 months across Technology Centers, creating real costs for startups seeking investor credibility, life sciences companies racing toward product launches, and technology firms defending competitive market position.
India IP
SR
S.S. Rana & Co. Advocates
Article
Intellectual Property Rights Newsletter August 2026
In ANI Media Pvt. Ltd. v. Open AI OpCo LLC, CS(COMM) 1028/2024, the Delhi High Court delivered a significant judgment on the intersection of copyright law and Generative Artificial Intelligence. Deciding an application for interim injunction, the Court examined questions concerning the use of copyrighted works for training Large Language Models (LLMs), the scope of copyright infringement arising from AI-generated outputs, the applicability of the fair dealing exception under Section 52 of the Copyright Act, 1957, and the territorial jurisdiction of Indian courts over AI developers operating through servers located overseas.
India IP
KS
King, Stubb & Kasiva
Article
IP And Investment Protections In The India-UK FTA
The India-UK Comprehensive Economic and Trade Agreement (CETA), in force since 15 July 2026, is often described in terms of tariffs and market access. But for businesses with valuable brands, patents, or cross-border investment plans, two other chapters matter just as much: intellectual property and investment. The two areas, however, have developed very differently under CETA. IP protection is comprehensive and detailed. Investment protection, by contrast, is conspicuously absent in the form most investors expect.
India IP
KS
King, Stubb & Kasiva
Article
Intellectual Property Newsletter | June 2026
The June 2026 edition of Dentons Link Legal IP & Technology Newsletter examines the global intellectual property ecosystem's strong momentum, featuring record-high filings, AI-driven innovation surges, and pivotal rulings that reflect technological advancement and evolving regulatory priorities. From bizarre patent cases like motorized pasta forks to multimillion-dollar verdicts collapsed by procedural flaws, the newsletter explores landmark decisions in pharmaceutical patents, trademark enforcement, and AI
India IP
DL
Dentons Link Legal
Article
Pharmaceutical Patent Architecture In India In Light Of TRIPS Obligations
India's pharmaceutical patent system navigates the delicate balance between protecting innovation and ensuring affordable access to life-saving medicines for millions living in poverty. Through mechanisms like compulsory licensing and restrictions on patent evergreening, the country attempts to honor its TRIPS obligations while maintaining its role as the "Pharmacy of the World." How effectively do these legal safeguards reconcile the competing interests of global pharmaceutical giants and public health nee
India IP
MC
MAHESHWARI & CO. Advocates & Legal Consultants
Article
When The File Moved On, The Order Stood Still: The Delhi High Court Remands Medilabo On Section 3(i)
The Delhi High Court in Medilabo RFP Inc. v. Controller of Patents[1] set aside a refusal under Section 3(i) of the Patents Act, 1970 concerning a pharmaceutical invention for neurodegenerative diseases, The Court’s intervention turned on a more fundamental principle of patent adjudication: the Controller must decide an application on the basis of the claims as they stand on the date of the order and must deal with every objection raised in the hearing notice through reasoned findings.
India IP
SR
S.S. Rana & Co. Advocates
Article
Who Owns What? The IP Rights That Arise From Employee-Created Artificial Intelligence Workflows
As employees adapt to utilizing AI technologies in generating their work output, there exists a major disconnect among IP laws (both globally and in India) regarding who owns the copyright, patent, or trade secret in a work that was produced using AI technologies. Is it the employer, employee, or AI tool provider; all three parties could have an interest in these types of works?
India IP
Ka
Khurana and Khurana
See more